Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · IEX Real-Time Price · USD
13.80
-0.04 (-0.29%)
Aug 8, 2022 4:00 PM EDT - Market closed
Cash Flow Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 |
|---|---|---|---|
| Net Income
|
-32.67 | -6.78 | -4 |
| Depreciation & Amortization
|
0.11 | 0.01 | 0.01 |
| Share-Based Compensation
|
6.91 | 0.07 | 0.01 |
| Other Operating Activities
|
8.67 | 2.33 | 0.16 |
| Operating Cash Flow
|
-16.98 | -4.37 | -3.83 |
| Capital Expenditures
|
-1.48 | 0 | 0 |
| Change in Investments
|
-339.48 | 0 | 0 |
| Investing Cash Flow
|
-340.96 | 0 | 0 |
| Share Issuance / Repurchase
|
205.98 | 0.07 | 0 |
| Debt Issued / Paid
|
0 | 2.5 | 4 |
| Other Financing Activities
|
180.55 | 8.95 | 0 |
| Financing Cash Flow
|
386.52 | 11.52 | 4 |
| Net Cash Flow
|
28.59 | 7.16 | 0.17 |
| Free Cash Flow
|
-18.46 | -4.37 | -3.83 |
| Free Cash Flow Margin
|
-507.51% | - | - |
| Free Cash Flow Per Share
|
-0.78 | -4.77 | -5.72 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).